148
Journals
668.9K
Articles
12.3M
Citations
108.5K
Authors

Most Cited Articles of Hematology in 2015

TitleJournalYearCitations
Global cancer statistics, 2012Ca-A Cancer Journal for Clinicians201520.7K
Cancer statistics, 2015Ca-A Cancer Journal for Clinicians201510.2K
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014Annals of Oncology20151.4K
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group reportBiology of Blood and Marrow Transplantation20151.2K
Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015Annals of Oncology20151.1K
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromesBlood20151K
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology2015962
Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodiesAnnals of Oncology2015828
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blastsBlood2015693
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology2015658
T cell subsets and their signature cytokines in autoimmune and inflammatory diseasesCytokine2015547
Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinibBlood2015529
Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTHJournal of Thrombosis and Haemostasis2015528
Oral cavity and oropharyngeal squamous cell carcinoma--an updateCa-A Cancer Journal for Clinicians2015512
Acute myeloid leukemia ontogeny is defined by distinct somatic mutationsBlood2015497
First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE studyAnnals of Oncology2015480
Exosomes in cancer: small particle, big playerJournal of Hematology and Oncology2015475
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancerInternational Journal of Clinical Oncology2015467
CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemiaBlood2015457
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)Annals of Oncology2015451
CT-based radiomic signature predicts distant metastasis in lung adenocarcinomaRadiotherapy and Oncology2015444
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemiaBlood2015431
Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group reportBlood2015426
Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations†Annals of Oncology2015424
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host DiseaseBiology of Blood and Marrow Transplantation2015415